ProPhase Labs, Inc. (PRPH)
| Market Cap | 118.78M |
| Revenue (ttm) | 111.30M |
| Net Income (ttm) | 17.71M |
| Shares Out | 15.49M |
| EPS (ttm) | 0.40 |
| PE Ratio | 19.42 |
| Forward PE | 26.04 |
| Dividend | $0.60 (7.82%) |
| Ex-Dividend Date | Feb 28, 2022 |
| Volume | 28,279 |
| Open | 7.68 |
| Previous Close | 7.65 |
| Day's Range | 7.60 - 7.90 |
| 52-Week Range | 4.44 - 8.58 |
| Beta | -0.01 |
| Analysts | Buy |
| Price Target | 11.22 (+46.3%) |
| Earnings Date | May 13, 2022 |
About PRPH
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production...
Financial Performance
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for PRPH stock is "Buy." The 12-month stock price forecast is 11.22, which is an increase of 46.28% from the latest price.
News
ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference
May 23-26, 2022 (HYBRID CONFERENCE)
ProPhase Labs, Inc. (PRPH) Tops Q1 Earnings and Revenue Estimates
ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of 74.36% and 95.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
ProPhase Labs Announces Record First Quarter 2022 Financial Results
Record Net Revenues of $47.5 Million, Up 211% Year-over-Year
ProPhase Labs to Present at the Spring Into Action – Best Ideas Virtual Investor Conference
Garden City, NY, May 11, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present at the...
ProPhase Labs Announces Appointment of Bill White as Chief Financial Officer
Garden City, NY, May 10, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified diagnostics and genomics company, announced today that Bill White has been appointed Chief Financial O...
ProPhase Labs to Host First Quarter 2022 Financial Results Conference Call on Friday, May 13, 2022 at 11:00 a.m. East...
GARDEN CITY, NY, May 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, will hold a conference call on Friday, May 13, 2022 at 11:00 a.m. ET...
ProPhase Labs to Present at the Planet MicroCap Showcase 2022 on Wednesday, May 4, 2022
Garden City, NY, April 27, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present a co...
All You Need to Know About ProPhase Labs, Inc. (PRPH) Rating Upgrade to Strong Buy
ProPhase Labs, Inc. (PRPH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
3 Top Breakout Stocks to Buy for Remarkable Returns
ProPhase Labs (PRPH), Hudson Technologies (HDSN) and YPF Sociedad Anonima (YPF) have been selected as the breakout stocks for today.
ProPhase Labs, Inc. (PRPH) Soars 11.2%: Is Further Upside Left in the Stock?
ProPhase Labs, Inc. (PRPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more s...
ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021
Record Financial Results also expected for Q1 2022
ProPhase Labs to Host Fourth Quarter and Full Year 2021 Financial Results Conference Call on Wednesday, March 30, 202...
GARDEN CITY, NY, March 24, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified company offering a range of services including diagnostic testing, genomics testing and contract man...
ProPhase Labs Announces Special Cash Dividend
Anticipates Record Q4 2021 and Q1 2022 Revenues and Profits
ProPhase Labs to Present at the MicroCap Rodeo Winter Wonderland Best Ideas Virtual Conference
GARDEN CITY, NY, Feb. 03, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the Mi...
ProPhase Labs Announces Record COVID-19 Testing in Q4 2021
Q1 2022 Testing Volumes will Significantly Exceed Previous Record Results from Q1 2021
ProPhase Labs Continues to Build Strong Leadership with Key Promotions and Additions to Management Team
Precision Medicine division adds Industry Veteran Sam A. Beeler as Chief Strategy Officer; Diagnostics Division Promotes Alice Lioi and Jason Karkus to EVP and Co-Chief Operating Officers and Sergio Mir...
PROPHASE LABS, INC. ANNOUNCES INDUCEMENT AWARD UNDER NASDAQ LISTING RULE 5635(C)(4)
GARDEN CITY, NY, Nov. 23, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that it has granted an inducement award to a new employee.
ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2021
Company to hold a conference call November 12 , 2021 at 11:00 AM ET
ProPhase Labs to Present at the Q4 Investor Summit Conference
GARDEN CITY, NY, Nov. 10, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will present at the Q4...
ProPhase Labs to Host Third Quarter 2021 Financial Results Conference Call on Friday, November 12, 2021 at 11:00 a.m....
GARDEN CITY, NY, Nov. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, will hold a conference call on Friday, November 12, 2021 at 11:00 a.m. ...
ProPhase Labs Provides Business Update
Garden City, NY, Oct. 13, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, today announces that it expects its Q3 2021 COVID-19 testing revenues t...
ProPhase Labs to Present at the LD Micro Main Event Conference
GARDEN CITY, NY, Oct. 06, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, announces today that Chairman and CEO Ted Karkus will be presenting vir...
ProPhase Labs to Present at Two Upcoming August Conferences
GARDEN CITY, NY, Aug. 16, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (Nasdaq: PRPH), a diversified biotech and genomics company, today announced that Chairman and CEO Ted Karkus is scheduled to presen...
Recap: ProPhase Labs Q2 Earnings
Shares of ProPhase Labs (NASDAQ:PRPH) rose 3.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 1000.00% over the past year to ($0.09), which ...
ProPhase Labs Announces Financial Results for the Quarter Ended June 30, 2021
Company Provides Update on Significant Resurgence in Covid testing and Additional Insights into Previously Announced Nebula Genomics Acquisition